Offer - Urjas Oil for just ₹ 1 X
Pregmate 50mg Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Is the use of Pregmate 50mg Tablet (10) safe for pregnant women?
Pregmate can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Pregmate right away. Take your doctor's advice before taking it again.
Is the use of Pregmate 50mg Tablet (10) safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Pregmate for breastfeeding women are not known.
What is the effect of Pregmate 50mg Tablet (10) on the Kidneys?
There are no side effects of Pregmate on the kidneys.
What is the effect of Pregmate 50mg Tablet (10) on the Liver?
Using Pregmate does not have any harmful effects on the liver.
What is the effect of Pregmate 50mg Tablet (10) on the Heart?
Pregmate may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Pregmate 50mg Tablet (10) unless your doctor advises you to do so -
Is this Pregmate 50mg Tablet (10) habit forming or addictive?
Forming a habit of Pregmate 50mg Tablet (10) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Pregmate 50mg Tablet (10) does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Pregmate 50mg Tablet (10) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Pregmate 50mg Tablet (10) is not used to treat mental disorders.
Interaction between Food and Pregmate 50mg Tablet (10)
Due to the absence of research, it is difficult to say how Pregmate 50mg Tablet (10) and food will interact.
Interaction between Alcohol and Pregmate 50mg Tablet (10)
No research has been done on this till date. Therefore, it is not known what the effect of taking Pregmate 50mg Tablet (10) with alcohol will be.
Yes, you can take Pregmate with folic acid. No clinically significant drug interaction has been reported between them. However, if you feel any discomfort after taking this drug along with folic acid then do not hesitate to inform your doctor.
Pregmate contains clomifene that is an ovulatory stimulant which works by stimulating the release of gonadotropin hormones such as luteinizing hormone (LH) and follicle stimulating hormones (FSH) from the pituitary gland in the brain. This leads to maturation of ovarian follicle and increases the circulating level of estradiol (female sex hormone) which induces ovulation.
Yes, Pregmate may cause hair loss. It is an infrequent and rare side effect of this drug. However, the exact cause of hair loss is unknown. If you are experiencing excessive hair loss after taking this drug, then you are advised to discuss it with your doctor.
Usually, Pregmate is given for short-term treatment up to 5 days if ovulation is not induced then this same treatment course is started after the interval of 30 days at higher doses. You are advised to take Pregmate as long as it is recommended by your doctor. Taking this drug beyond that period might not be good for you because it can lead to unintended side effects.
Yes, Pregmate is antiestrogen because it is a weak estrogen receptor antagonist that weakly affects the estrogen from mediating its biological effect which in turn stimulates the release of gonadotropin hormones both in men and women.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Clomid® (clomiphene citrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 312